This inventor holds 2 USPTO granted patents. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations by Hyun-Ju Lee: Pioneering mTOR Regulation
Introduction
Hyun-Ju Lee, an accomplished inventor based in Pohang, South Korea, has made significant contributions to the field of metabolic disease treatment through innovative methods that regulate the mammalian target-of-rapamycin (mTOR). With a total of two patents, Lee's work reflects a deep understanding of the biochemical interactions that influence metabolic pathways.
Latest Patents
Hyun-Ju Lee's latest patents focus on the regulation of mTOR activity through interactions with phospholipase D (PLD) and other key molecules. The first patent, titled "Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor," outlines a method for regulating mTOR by generating a complex with PLD. This invention not only addresses the regulation of mTOR but also provides a method for screening inhibitors and offers a composition for treating mTOR-related metabolic diseases.
The second patent, "Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and Rheb," presents a novel mechanism of regulating mTOR through the interaction of PLD and Rheb. Similar to the first, this invention includes methods for screening inhibitors of mTOR and developing treatments for metabolic diseases associated with its dysregulation.
Career Highlights
Hyun-Ju Lee is affiliated with the POSTECH Academy-Industry Foundation, a prominent institution in South Korea known for fostering collaboration between academia and industry. His work demonstrates a commitment to advancing scientific knowledge and its application to real-world medical challenges.
Collaborations
In his research endeavors, Lee collaborates with respected colleagues, including Sung-Ho Ryu and Pann-Ghill Suh. Their collective expertise enhances the innovation process and contributes to the development of effective therapeutic strategies targeting mTOR pathways.
Conclusion
Hyun-Ju Lee's inventive contributions to the regulation of mTOR reflect his dedication to addressing metabolic diseases through cutting-edge research. His patents provide a foundation for further investigation and therapeutic development, showcasing the importance of collaboration in driving innovation within the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile